Agios Pharmaceuticals to Seek FDA Accelerated Approval for Pyrukynd Label Expansion

Agios Pharmaceuticals announced plans to pursue accelerated approval from the FDA for the expansion of its Pyrukynd drug label, leading to gains for the company.